(secondQuint)A Trial of a Single Delivery of SB-061 in Osteoarthritis of the Knee.

 The treatment of pain associated with osteoarthritis may include periodic intra-articular injections of corticosteroids or viscosupplements such as hyaluronic acid.

 SB-061 is anticipated to relieve osteoarthritis pain by reinforcing the cartilage matrix and providing a lubricating coating of the cartilage.

 Subjects will receive 1 intra-articular injection of either SB-061 or placebo and be followed for 3 months to evaluate pain amelioration.

 Subjects and Investigators are blinded to treatment allocation.

.

 A Trial of a Single Delivery of SB-061 in Osteoarthritis of the Knee@highlight

This study evaluates a novel agent, SB-061, for the treatment of osteoarthritis of the knee.

 Half of the patients will receive the agent via intra-articular injection and half will receive a placebo injection.

